Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for flu vaccine efficacy in older adults
NCT03996538Phase 1Completed
- Sponsor
- UConn Health
- Start
- Jun 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of metformin in immunosenescence, sponsored by UConn Health. Primary endpoint: Cell-mediated Flu Vaccine Responses - inducible Granzyme B at 17 weeks. Started Jun 2019; status: completed.
02
Drugs
metformin
03
Conditions
immunosenescence
Beyond the preview
Go deeper on NCT03996538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03996538.